Status:
RECRUITING
Brain Neuronal Networks, Chemosensory and Trigeminal Functions in Allo-HSCT
Lead Sponsor:
University of Oslo
Conditions:
Hematopoietic Stem Cell Transplantation
Eligibility:
All Genders
30-50 years
Brief Summary
The goal of this prospective, cohort study is to learn about smell, taste and trigeminal dysfunction in patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT). The research ...
Detailed Description
Participants will undergo various tests: * Smell function assessment with Sniffin' Sticks. * Taste function assessment with Taste Strips. * Oral trigeminal function assessment with von Frey filaments...
Eligibility Criteria
Inclusion
- • patients receiving myeloablative conditioning for a first-time allo-HSCT and diagnosed with either a leukemia or a myelodysplastic syndrome
Exclusion
- disorders affecting the oral cavity including poor tooth-status
- those using drugs affecting the gustatory/olfactory functions
- those with brain disorders
- those who have a chronic disorder affecting the immune system, have cancer or who are pregnant.
Key Trial Info
Start Date :
August 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06003660
Start Date
August 10 2023
End Date
June 30 2026
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oslo
Oslo, Oslo County, Norway, 0254